Elli Peselev

Array ( [id] => 3652025 [patent_doc_number] => 05606037 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => 'Processes antineoplastic heteronaphthoquinones' [patent_app_type] => 1 [patent_app_number] => 8/401492 [patent_app_country] => US [patent_app_date] => 1995-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 122294 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/606/05606037.pdf [firstpage_image] =>[orig_patent_app_number] => 401492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3663434 [patent_doc_number] => 05656735 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Process for the preparation of amikacin precursors' [patent_app_type] => 1 [patent_app_number] => 8/402328 [patent_app_country] => US [patent_app_date] => 1995-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5592 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656735.pdf [firstpage_image] =>[orig_patent_app_number] => 402328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3732923 [patent_doc_number] => 05693751 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Water soluble high molecular weight polymerized drug preparation' [patent_app_type] => 1 [patent_app_number] => 8/400905 [patent_app_country] => US [patent_app_date] => 1995-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 2616 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693751.pdf [firstpage_image] =>[orig_patent_app_number] => 400905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623064 [patent_doc_number] => 05602103 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Cerebral function-ameliorating agent' [patent_app_type] => 1 [patent_app_number] => 8/398238 [patent_app_country] => US [patent_app_date] => 1995-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 1265 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602103.pdf [firstpage_image] =>[orig_patent_app_number] => 398238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3663950 [patent_doc_number] => 05625043 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Anthracyclines with unusually high activity against cells resistant to doxorubicin and its analogs' [patent_app_type] => 1 [patent_app_number] => 8/396290 [patent_app_country] => US [patent_app_date] => 1995-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7524 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/625/05625043.pdf [firstpage_image] =>[orig_patent_app_number] => 396290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3622484 [patent_doc_number] => 05614614 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-25 [patent_title] => 'Eryhromycin derivatives' [patent_app_type] => 1 [patent_app_number] => 8/391959 [patent_app_country] => US [patent_app_date] => 1995-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7656 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 278 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/614/05614614.pdf [firstpage_image] =>[orig_patent_app_number] => 391959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3625630 [patent_doc_number] => 05608044 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Pradimic acids, amides, and pradimicin derivatives' [patent_app_type] => 1 [patent_app_number] => 8/385021 [patent_app_country] => US [patent_app_date] => 1995-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11878 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/608/05608044.pdf [firstpage_image] =>[orig_patent_app_number] => 385021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3691745 [patent_doc_number] => 05604208 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-18 [patent_title] => 'Antibiotic preparation and use of the same in plants' [patent_app_type] => 1 [patent_app_number] => 8/380442 [patent_app_country] => US [patent_app_date] => 1995-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2666 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/604/05604208.pdf [firstpage_image] =>[orig_patent_app_number] => 380442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770010 [patent_doc_number] => 05733891 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Compound for medicinal ingredient and hyaluronic acid and process for producing the same' [patent_app_type] => 1 [patent_app_number] => 8/380324 [patent_app_country] => US [patent_app_date] => 1995-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 10282 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/733/05733891.pdf [firstpage_image] =>[orig_patent_app_number] => 380324 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686587 [patent_doc_number] => 05663151 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/379381 [patent_app_country] => US [patent_app_date] => 1995-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51762 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663151.pdf [firstpage_image] =>[orig_patent_app_number] => 379381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3816599 [patent_doc_number] => 05770579 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Erythromycin compounds' [patent_app_type] => 1 [patent_app_number] => 8/378186 [patent_app_country] => US [patent_app_date] => 1995-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17399 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 702 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770579.pdf [firstpage_image] =>[orig_patent_app_number] => 378186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686605 [patent_doc_number] => 05663152 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Potentiators for aminoglycosides' [patent_app_type] => 1 [patent_app_number] => 8/375433 [patent_app_country] => US [patent_app_date] => 1995-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3278 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663152.pdf [firstpage_image] =>[orig_patent_app_number] => 375433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658719 [patent_doc_number] => 05627162 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-06 [patent_title] => 'Methods and means for control of proliferation of remnant cells following surgery' [patent_app_type] => 1 [patent_app_number] => 8/374360 [patent_app_country] => US [patent_app_date] => 1995-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 4683 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/627/05627162.pdf [firstpage_image] =>[orig_patent_app_number] => 374360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3553175 [patent_doc_number] => 05574020 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-12 [patent_title] => 'Tilmicosin formulation' [patent_app_type] => 1 [patent_app_number] => 8/372697 [patent_app_country] => US [patent_app_date] => 1995-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 900 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/574/05574020.pdf [firstpage_image] =>[orig_patent_app_number] => 372697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3547418 [patent_doc_number] => 05545624 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-13 [patent_title] => 'Derivatives of 16-membered ring antibiotic macrolides' [patent_app_type] => 1 [patent_app_number] => 8/362496 [patent_app_country] => US [patent_app_date] => 1995-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11897 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/545/05545624.pdf [firstpage_image] =>[orig_patent_app_number] => 362496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3588040 [patent_doc_number] => 05585251 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'Fungal isolates, fusacandins' [patent_app_type] => 1 [patent_app_number] => 8/370934 [patent_app_country] => US [patent_app_date] => 1995-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6250 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585251.pdf [firstpage_image] =>[orig_patent_app_number] => 370934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3533359 [patent_doc_number] => 05556839 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-17 [patent_title] => 'Form II Dirithromycin' [patent_app_type] => 1 [patent_app_number] => 8/369980 [patent_app_country] => US [patent_app_date] => 1995-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5842 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/556/05556839.pdf [firstpage_image] =>[orig_patent_app_number] => 369980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3945778 [patent_doc_number] => 05977082 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Injectable ready-to-use solutions containing an antitumor anthracycline glycoside' [patent_app_type] => 1 [patent_app_number] => 8/368402 [patent_app_country] => US [patent_app_date] => 1995-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 11843 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/977/05977082.pdf [firstpage_image] =>[orig_patent_app_number] => 368402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939259 [patent_doc_number] => 05872104 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Combinations and methods for reducing antimicrobial resistance' [patent_app_type] => 1 [patent_app_number] => 8/364246 [patent_app_country] => US [patent_app_date] => 1994-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 36275 [patent_no_of_claims] => 132 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/872/05872104.pdf [firstpage_image] =>[orig_patent_app_number] => 364246 [rel_patent_id] =>[rel_patent_doc_number] =>)